{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T06:54:58Z","timestamp":1786776898689,"version":"build-2736575974"},"reference-count":22,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"1","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Oncology Practice"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec><jats:title>PURPOSE:<\/jats:title><jats:p> Because clinical specialists often lack time and training to address secondary health issues such as smoking cessation, the National Cancer Institute Cancer Center Cessation Initiative (C3I) has mobilized cancer centers to develop systems for treating patients' tobacco dependence. <\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS:<\/jats:title><jats:p> One university-based cancer center was able to develop a program that formalized smoking treatment using a collaborative, multidisciplinary care team with overlapping expertise in cancer care, medication management, and tobacco cessation. Program planners delivered tobacco cessation services in the outpatient setting by automating identification of eligible patients using a tobacco registry in the electronic health records, directly involving oncology pharmacists in medication oversight, using dedicated tobacco treatment specialists to provide cessation services, and engaging oncologists through active communications protocols. Evaluators used Practical Robust Implementation and Sustainability Model as the guiding framework for a qualitative assessment of program development and implementation. Evaluators also measured provider satisfaction and utilization of services, program reach, and smoking cessation outcomes 6 months post enrollment. <\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS:<\/jats:title><jats:p> During the evaluation period (July 1, 2018-September 30, 2019), the smoking cessation program engaged 96% of eligible patients (n = 214 of 223 eligible); 82% of those enrolled in the program (n = 183). At 6-month follow-up, 29.1% of enrolled patients self-reported 30-day point prevalence abstinence (n = 53) and 34.9% (n = 64) reported 7-day point prevalence abstinence (intent-to-treat rates). <\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSION:<\/jats:title><jats:p> Using a team-based approach that leverages individual expertise and interprofessional collaboration to provide patient-centered treatment, a smoking cessation program can identify and treat eligible patients in specialty clinics. <\/jats:p><\/jats:sec>","DOI":"10.1200\/op.22.00273","type":"journal-article","created":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T20:59:24Z","timestamp":1671051564000},"page":"e115-e124","update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":7,"title":["Developing a Collaborative, Team-Based Smoking Cessation Treatment Program in an Outpatient Oncology Setting"],"prefix":"10.1200","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2123-0879","authenticated-orcid":true,"given":"Sara L.","family":"Cooper","sequence":"first","affiliation":[{"name":"Department of Community and Behavioral Health, University of Colorado School of Public Health, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladka","family":"Kovar","sequence":"additional","affiliation":[{"name":"Department of Community and Behavioral Health, University of Colorado School of Public Health, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3167-0384","authenticated-orcid":true,"given":"Arnold H.","family":"Levinson","sequence":"additional","affiliation":[{"name":"Department of Community and Behavioral Health, University of Colorado School of Public Health, Aurora, CO"},{"name":"University of Colorado Cancer Center, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"b1","volume-title":"National Comprehensive Cancer Network Smoking Cessation Guidelines Panel","author":"Shields PG","year":"2019"},{"key":"b2","volume-title":"Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline","author":"Fiore MC","year":"2008"},{"key":"b3","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.9072"},{"key":"b4","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-12-784"},{"key":"b6","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.1703"},{"key":"b7","volume-title":"National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines): Smoking Cessation 1","author":"Shields PG","year":"2015"},{"key":"b8","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21598"},{"key":"b9","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e318288dc96"},{"key":"b10","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2013.001025"},{"key":"b11","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25828"},{"key":"b12","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.12251"},{"key":"b13","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17145034"},{"key":"b14","doi-asserted-by":"publisher","DOI":"10.2217\/cer-2020-0004"},{"key":"b15","doi-asserted-by":"publisher","DOI":"10.1016\/j.suronc.2011.06.004"},{"key":"b16","first-page":"228","volume":"34","author":"Feldstein AC","year":"2008","journal-title":"Jt Comm J Qual Patient Saf"},{"key":"b17","doi-asserted-by":"publisher","DOI":"10.1002\/onco.13856"},{"key":"b18","volume-title":"Practice Guidance for Expanding Pharmacy-Based Tobacco Cessation Services Within the Appointment-Based Model [Webinar]. Smoking Cessation Leadership Center. Webinar: Pharmacists Prescribing for Tobacco Cessation Medications","author":"Hudmin KS","year":"2022"},{"key":"b19","volume-title":"Colorado State Board of Pharmacy Approved Statewide Protocol for Dispensing Tobacco Cessation Products (Rule 17, Appendix B)","author":"Colorado Department of Regulatory Agencies"},{"key":"b20","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2018-0246"},{"key":"b21","doi-asserted-by":"publisher","DOI":"10.1111\/add.12734"},{"key":"b22","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol28020115"},{"key":"b23","doi-asserted-by":"publisher","DOI":"10.3747\/co.25.3921"}],"container-title":["JCO Oncology Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/OP.22.00273","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T23:00:41Z","timestamp":1673478041000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/OP.22.00273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["10.1200\/OP.22.00273"],"URL":"https:\/\/doi.org\/10.1200\/op.22.00273","relation":{},"ISSN":["2688-1527","2688-1535"],"issn-type":[{"value":"2688-1527","type":"print"},{"value":"2688-1535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"2022-04-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-19","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}